The use of insulin in cystic fibrosis-related diabetes: A philosophical difference from the use of insulin in Type 1 and Type 2 diabetes

Pediatric Pulmonology

Volumn 47, Issue 11, 2012, Pages 1039-1041

  Bremer, Andrew A ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

BODY MASS; CARBOHYDRATE INTAKE; CYSTIC FIBROSIS; CYSTIC FIBROSIS RELATED DIABETES; DIABETIC PATIENT; DISEASE ASSOCIATION; DRUG EFFICACY; EDITORIAL; GLYCEMIC CONTROL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; LUNG FUNCTION; LUNG FUNCTOIN; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CHILD; CYSTIC FIBROSIS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; RESPIRATORY TRACT INFECTIONS; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84867743905     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.22662     Document Type: Editorial

References (22)

1. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, Robinson KA, Sabadosa KA, Stecenko A, Slovis B,. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care 2010; 33: 2697-2708.
2. Moran A, Dunitz J, Nathan B, Saeed A, Holme B, Thomas W,. Cystic fibrosis-related diabetes: current trends in prevalence, incidence, and mortality. Diabetes Care 2009; 32: 1626-1631.
3. Adler AI, Shine BS, Chamnan P, Haworth CS, Bilton D,. Genetic determinants and epidemiology of cystic fibrosis-related diabetes: results from a British cohort of children and adults. Diabetes Care 2008; 31: 1789-1794.
4. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ,. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005; 146: 681-687.
5. Koch C, Rainisio M, Madessani U, Harms HK, Hodson ME, Mastella G, McKenzie SG, Navarro J, Strandvik B,. Presence of cystic fibrosis-related diabetes mellitus is tightly linked to poor lung function in patients with cystic fibrosis: data from the European Epidemiologic Registry of Cystic Fibrosis. Pediatr Pulmonol 2001; 32: 343-350.
6. Moran A, Becker D, Casella SJ, Gottlieb PA, Kirkman MS, Marshall BC, Slovis B,. Epidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review. Diabetes Care 2010; 33: 2677-2683.
7. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993; 329: 977-986.
8. Nathan DM, Zinman B, Cleary PA, Backlund JY, Genuth S, Miller R, Orchard TJ,. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med 2009; 169: 1307-1316.
9. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA,. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008; 359: 1577-1589.
10. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
11. Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N, Czernichow P, Polak M,. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001; 90: 860-867.
12. Lanng S, Thorsteinsson B, Nerup J, Koch C,. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151: 684-687.
13. Finkelstein SM, Wielinski CL, Elliott GR, Warwick WJ, Barbosa J, Wu SC, Klein DJ,. Diabetes mellitus associated with cystic fibrosis. J Pediatr 1988; 112: 373-377.
14. Milla CE, Warwick WJ, Moran A,. Trends in pulmonary function in patients with cystic fibrosis correlate with the degree of glucose intolerance at baseline. Am J Respir Crit Care Med 2000; 162: 891-895.
15. Franzese A, Spagnuolo MI, Sepe A, Valerio G, Mozzillo E, Raia V,. Can glargine reduce the number of lung infections in patients with cystic fibrosis-related diabetes ? Diabetes Care 2005; 28: 2333.
16. Lanng S, Thorsteinsson B, Lund-Andersen C, Nerup J, Schiotz PO, Koch C,. Diabetes mellitus in Danish cystic fibrosis patients: prevalence and late diabetic complications. Acta Paediatr 1994; 83: 72-77.
17. Mohan K, Israel KL, Miller H, Grainger R, Ledson MJ, Walshaw MJ,. Long-term effect of insulin treatment in cystic fibrosis-related diabetes. Respiration 2008; 76: 181-186.
18. Nousia-Arvanitakis S, Galli-Tsinopoulou A, Karamouzis M,. Insulin improves clinical status of patients with cystic-fibrosis-related diabetes mellitus. Acta Paediatr 2001; 90: 515-519.
19. Moran A, Pekow P, Grover P, Zorn M, Slovis B, Pilewski J, Tullis E, Liou TG, Allen H,. Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial. Diabetes Care 2009; 32: 1783-1788.
20. Bizzarri C, Lucidi V, Ciampalini P, Bella S, Russo B, Cappa M,. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. J Endocrinol Invest 2006; 29: RC1-RC4.
21. Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL, Philips BJ, Geddes DM, Hodson ME, Baker EH,. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 2007; 6: 101-109.
22. Ntimbane T, Krishnamoorthy P, Huot C, Legault L, Jacob SV, Brunet S, Levy E, Gueraud F, Lands LC, Comte B,. Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children. J Cyst Fibros 2008; 7: 373-384.